MALAT1 and hepatocellular carcinoma: Moreover, lncRNA MALAT1 was reported to be overexpressed in multiple cancer types, such as colorectal cancer, non-small cell lung cancer and hepatocellular carcinoma (HCC); its expression was also correlated with tumor progression and poor prognosis (15–18).